156 related articles for article (PubMed ID: 38552108)
21. [Sarcoma of the breast: what is the contribution of immunohistochemistry and flow cytometry?].
Haberthür F; Feichter GE; Torhorst JK
Geburtshilfe Frauenheilkd; 1993 Nov; 53(11):811-3. PubMed ID: 8293949
[TBL] [Abstract][Full Text] [Related]
22. Repeat sentinel lymph node surgery for locally recurrent breast cancer after prior mastectomy.
Schulze AK; Hoskin TL; Mrdutt MM; Mutter RW; Hieken TJ
J Surg Oncol; 2024 Mar; 129(3):461-467. PubMed ID: 37929785
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.
Dogan I; Aydin E; Khanmammadov N; Paksoy N; Ferhatoğlu F; Ak N; Emiroglu S; Ibis K; Onder S; Tukenmez M; Cabioglu N; Kucucuk S; Muslumanoğlu M; Ozmen V; Saip P; Igci A; Aydiner A
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14833-14841. PubMed ID: 37594533
[TBL] [Abstract][Full Text] [Related]
24. Axillary treatment for operable primary breast cancer.
Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
[TBL] [Abstract][Full Text] [Related]
25. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Br J Surg; 2021 Sep; 108(9):1105-1111. PubMed ID: 34010418
[TBL] [Abstract][Full Text] [Related]
26. Primary sarcoma of the breast.
Pandey M; Mathew A; Abraham EK; Rajan B
J Surg Oncol; 2004 Sep; 87(3):121-5. PubMed ID: 15334638
[TBL] [Abstract][Full Text] [Related]
27. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients.
Heuts EM; van der Ent FW; Hulsewé KW; Heeren PA; Hoofwijk AG
Acta Chir Belg; 2007 Jun; 107(3):279-83. PubMed ID: 17685253
[TBL] [Abstract][Full Text] [Related]
28. Pre-operative and intra-operative detection of axillary lymph node metastases in 108 patients with invasive lobular breast cancer undergoing mastectomy.
Novak J; Besic N; Dzodic R; Gazic B; Vogrin A
BMC Cancer; 2018 Feb; 18(1):137. PubMed ID: 29402252
[TBL] [Abstract][Full Text] [Related]
29. The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
van Roozendaal LM; de Wilt JH; van Dalen T; van der Hage JA; Strobbe LJ; Boersma LJ; Linn SC; Lobbes MB; Poortmans PM; Tjan-Heijnen VC; Van de Vijver KK; de Vries J; Westenberg AH; Kessels AG; Smidt ML
BMC Cancer; 2015 Sep; 15():610. PubMed ID: 26335105
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.
Wang F; Jia Y; Tong Z
Jpn J Clin Oncol; 2015 Feb; 45(2):146-52. PubMed ID: 25387733
[TBL] [Abstract][Full Text] [Related]
31. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
[TBL] [Abstract][Full Text] [Related]
32. An analysis of 78 breast sarcoma patients without distant metastases at presentation.
McGowan TS; Cummings BJ; O'Sullivan B; Catton CN; Miller N; Panzarella T
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):383-90. PubMed ID: 10661345
[TBL] [Abstract][Full Text] [Related]
33. Long-term risk of sarcoma following radiation treatment for breast cancer.
Taghian A; de Vathaire F; Terrier P; Le M; Auquier A; Mouriesse H; Grimaud E; Sarrazin D; Tubiana M
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):361-7. PubMed ID: 1648044
[TBL] [Abstract][Full Text] [Related]
34. Extent of surgical procedure in triple negative breast carcinomas.
Kotal J; Petrů V; Kosáč P; Vážan P; Zábojníková M; Jančík P; Ratajský M; Lajmar K; Dudešek B; Duben J; Holík P; Gatěk J
Rozhl Chir; 2023; 102(4):159-164. PubMed ID: 37344196
[TBL] [Abstract][Full Text] [Related]
35. Axillary management in patients with breast cancer and positive axilla at diagnosis. Experience in a Spanish university hospital with a 5-year follow-up.
Jimenez-Gomez M; Loro-Pérez J; Vega-Benítez V; Hernández-Hernández JR; Aguirre NA
J Cancer Res Ther; 2023; 19(2):183-190. PubMed ID: 37313900
[TBL] [Abstract][Full Text] [Related]
36. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
[TBL] [Abstract][Full Text] [Related]
37. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
38. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
Danforth DN; Zujewski J; O'Shaughnessy J; Riseberg D; Steinberg SM; McAtee N; Noone M; Chow C; Chaudhry U; Lippman M; Jacobson J; Okunieff P; Cowan KH
Ann Surg Oncol; 1998 Mar; 5(2):150-8. PubMed ID: 9527268
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
[TBL] [Abstract][Full Text] [Related]
40. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
